RADIESSE – 1 x 1.5ml
Buy Radiesse 1.5ml online for professional aesthetic use. RADIESSE is a calcium hydroxylapatite (CaHA) injectable implant designed for soft-tissue augmentation and facial volume restoration.
RADIESSE 1.5ml Injectable Implant
RADIESSE is a well-established injectable implant from Merz Aesthetics, formulated with synthetic calcium hydroxylapatite suspended in a gel carrier.
The product is supplied as a 1 × 1.5ml pre-filled syringe and is intended for use by appropriately trained healthcare professionals in accordance with the applicable product documentation and local regulations.
Key Features
- Synthetic calcium hydroxylapatite (CaHA)
- 1 × 1.5ml pre-filled syringe
- Sterile formulation
- Latex-free
- Non-pyrogenic
- Semi-solid cohesive implant
- CaHA particle size of 25–45 microns
- Gel carrier based on sterile water, glycerin and sodium carboxymethylcellulose
- Designed for professional soft-tissue augmentation
- Merz Aesthetics product
- Professional-use medical device
Calcium Hydroxylapatite (CaHA) Technology
Unlike hyaluronic-acid dermal fillers, RADIESSE uses synthetic calcium hydroxylapatite particles suspended in an aqueous gel carrier.
The current Merz IFU specifies 56% CaHA particles by weight and 44% gel, with the gel consisting primarily of sterile water for injection, glycerin and sodium carboxymethylcellulose.
Facial Volume & Soft-Tissue Augmentation
RADIESSE 1.5ml is intended for professional soft-tissue augmentation. Current Merz documentation identifies indications including treatment of nasolabial folds and cheek augmentation, as well as certain volume-restoration applications.
RADIESSE is therefore suited to professional aesthetic practices looking for a CaHA-based option for facial augmentation rather than a conventional HA-only dermal filler.
RADIESSE vs RADIESSE (+) Lidocaine
It is important to distinguish the standard RADIESSE formulation from RADIESSE (+) Lidocaine.
RADIESSE 1.5ml contains synthetic calcium hydroxylapatite in its gel carrier without lidocaine. RADIESSE (+) Lidocaine is a separate formulation containing 0.3% lidocaine hydrochloride.
When ordering, check the exact product name and packaging to ensure you receive the intended formulation.
Product Specifications
| Specification | Details |
|---|---|
| Product | RADIESSE |
| Brand | RADIESSE |
| Manufacturer | Merz Aesthetics |
| Product type | Injectable implant |
| Primary material | Synthetic calcium hydroxylapatite |
| Volume | 1.5ml |
| Presentation | 1 × pre-filled syringe |
| CaHA particle size | 25–45 microns |
| Carrier | Sterile water, glycerin & sodium carboxymethylcellulose |
| Characteristics | Sterile, latex-free, non-pyrogenic |
| Primary positioning | Soft-tissue augmentation |
| Use | Professional healthcare use |
The current Merz 1.5ml IFU confirms the 1.5ml presentation, CaHA composition and professional intended use.
Why Choose RADIESSE 1.5ml?
RADIESSE provides aesthetic professionals with a calcium hydroxylapatite-based alternative to hyaluronic acid fillers. Its established CaHA formulation is designed for professional soft-tissue augmentation and facial volume restoration.
For clinics seeking the original RADIESSE formulation without integrated lidocaine, the 1 × 1.5ml presentation provides a clearly defined product option within the Merz Aesthetics portfolio.
Professional Use Only
RADIESSE is an injectable medical device intended for administration by appropriately trained healthcare professionals who are qualified or accredited according to applicable national law.
Not intended for self-administration. Always consult the current manufacturer Instructions for Use applicable to your market before professional use.
Reviews
There are no reviews yet.